Portal hypertension: Difference between revisions

Jump to navigation Jump to search
Prashanthsaddala (talk | contribs)
Line 66: Line 66:
===Causes by Organ System===
===Causes by Organ System===


{|style="width:80%; height:100px" border="1"
{|style="width:70%; height:100px" border="1"
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular'''
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular'''
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Cardiomyopathy]], [[Congestive heart failure]], [[Constructive pericarditis]], [[Inferior vena cava obstruction]], [[Splanchnic arteriovenous fistula]], [[Tricuspid insufficiency ]]
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Cardiomyopathy]], [[Congestive heart failure]], [[Constructive pericarditis]], [[Inferior vena cava obstruction]], [[Splanchnic arteriovenous fistula]], [[Tricuspid insufficiency ]]

Revision as of 12:04, 23 September 2012

Portal hypertension
The portal vein and its tributaries.
ICD-10 K76.6
ICD-9 572.3
DiseasesDB 10388
eMedicine radio/570  med/1889
MeSH D006975

WikiDoc Resources for Portal hypertension

Articles

Most recent articles on Portal hypertension

Most cited articles on Portal hypertension

Review articles on Portal hypertension

Articles on Portal hypertension in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Portal hypertension

Images of Portal hypertension

Photos of Portal hypertension

Podcasts & MP3s on Portal hypertension

Videos on Portal hypertension

Evidence Based Medicine

Cochrane Collaboration on Portal hypertension

Bandolier on Portal hypertension

TRIP on Portal hypertension

Clinical Trials

Ongoing Trials on Portal hypertension at Clinical Trials.gov

Trial results on Portal hypertension

Clinical Trials on Portal hypertension at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Portal hypertension

NICE Guidance on Portal hypertension

NHS PRODIGY Guidance

FDA on Portal hypertension

CDC on Portal hypertension

Books

Books on Portal hypertension

News

Portal hypertension in the news

Be alerted to news on Portal hypertension

News trends on Portal hypertension

Commentary

Blogs on Portal hypertension

Definitions

Definitions of Portal hypertension

Patient Resources / Community

Patient resources on Portal hypertension

Discussion groups on Portal hypertension

Patient Handouts on Portal hypertension

Directions to Hospitals Treating Portal hypertension

Risk calculators and risk factors for Portal hypertension

Healthcare Provider Resources

Symptoms of Portal hypertension

Causes & Risk Factors for Portal hypertension

Diagnostic studies for Portal hypertension

Treatment of Portal hypertension

Continuing Medical Education (CME)

CME Programs on Portal hypertension

International

Portal hypertension en Espanol

Portal hypertension en Francais

Business

Portal hypertension in the Marketplace

Patents on Portal hypertension

Experimental / Informatics

List of terms related to Portal hypertension

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Assistant Editor-in-Chief: Soumya Sachdeva

Overview

In medicine, portal hypertension is hypertension (high blood pressure) in the portal stem which causes an obstruction in the portal vein and its branches. It is often defined as a portal pressure gradient (the difference in pressure between the portal vein and the hepatic veins) of 12 mm Hg or greater. Many conditions can result in portal hypertension. In North America and Europe, it is usually the result of an intrahepatic block due to cirrhosis of the liver. However, in less industrialized parts of the world, climate permitting, the major cause is schistosomiasis.

Pathophysiology

Portal venous pressure is determined by-portal blood flow and portal vascular resistance.Increased portal vascular resistance is often the main factor responsible for it. The consequences of portal hypertension are due to blood being forced down alternate channels by the increased resistance to flow through the portal system. Due to formation of alternate channels initially some of the portal blood and later most of it is shunted directly to the systemic circularion bypassing the liver

Natural History and Complications

There is an increased risk of

Causes

Prehepatic

Intrahepatic

Posthepatic

Common Causes

Causes by Organ System

Cardiovascular Cardiomyopathy, Congestive heart failure, Constructive pericarditis, Inferior vena cava obstruction, Splanchnic arteriovenous fistula, Tricuspid insufficiency
Chemical / poisoning No underlying causes
Dermatologic NISCH syndrome
Drug Side Effect Didanosine, Thioguanine
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic Alcoholic hepatitis, Biliary atresia, Budd-Chiari syndrome, Cholestasis, Chronic hepatitis, Chronic liver disease, Cirrhosis, Congenital atresia or stenosis of portal vein, Congenital hepatic fibrosis, Congenital narrowing of the portal vein, Cruveilhier-Baumgarten syndrome, Fatty liver, Focal nodular hyperplasia, Fulminant hepatic failure, Hepatic amyloidosis with intrahepatic cholestasis, Hepatic arterioportal fistula, Hepatic portal vein obstruction, Hepatic vein occlusion, Hepatic vein thrombosis, Hepatic venoocclusive disease with immunodeficiency, Idiopathic liver cirrhosis, Idiopathic portal hypertension , Idiopathic tropical splenomegaly, Liver fibrosis, Mosse syndrome, Neonatal hepatitis, Nodular regenerative hyperplasia of the liver, Obliterative portal venopathy, Partial nodular transformation, Portal hypertension due to intrahepatic block, Portal vein abnormality, Portal vein compression, Portal vein occlusion, Portal vein thrombosis , Primary biliary cirrhosis, Primary sclerosing cholangitis, Splenic vein thrombosis, Alpha-1-antitrypsin deficiency, Progressive familial intrahepatic cholestasis, Berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification, Hepatic metastasis

Pancreatic cancer, NISCH syndrome

Genetic Alpha-1-antitrypsin deficiency, COACH syndrome, Cystic fibrosis, Gaucher disease, Glycosylphosphatidylinositol deficiency, Hemochromatosis, Interferon gamma receptor 1 deficiency, NISCH syndrome, Progressive familial intrahepatic cholestasis, Wilson's Disease , Hepatic venoocclusive disease with immunodeficiency
Hematologic Blackfan Diamond anemia, Congenital pure red cell aplasia , Myeloproliferative diseases, Mosse syndrome, Hemochromatosis, Osteomyelosclerosis, Hodgkin's lymphoma
Iatrogenic No underlying causes
Infectious Disease Schistosomiasis , Umbilical sepsis , Viral hepatitis
Musculoskeletal / Ortho Osteomyelosclerosis
Neurologic Berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification
Nutritional / Metabolic Gaucher disease, Glycosylphosphatidylinositol deficiency, Wilson's Disease
Obstetric/Gynecologic No underlying causes
Oncologic Extrinsic compression (tumors), Hepatic metastasis, Hodgkin's lymphoma, Pancreatic cancer
Opthalmologic No underlying causes
Overdose / Toxicity Didanosine, Thioguanine
Psychiatric No underlying causes
Pulmonary Cystic fibrosis, Alpha-1-antitrypsin deficiency, Berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification
Renal / Electrolyte Polycystic kidney disease
Rheum / Immune / Allergy Hepatic venoocclusive disease with immunodeficiency, Granulomatous diseases (sarcoidosis, tuberculosis), Sarcoidosis
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Dental No underlying causes
Miscellaneous Granulomatous diseases (sarcoidosis, tuberculosis), Sarcoidosis, Extrinsic compression (tumors)

Causes in Alphabetical Order


Diagnosis

Physical Examination

Abdomen

Investigations

  1. Barim swallow - presence of varices is seen as filling defects(bag of worms appearnace)
  2. Upper gastrointestinal endoscopy - presence of cherry red spots.Very reliable
  3. Ultrasonography - to note the size of liver,spleen,poratl vein,splenic vein and to look for the presence of collaterals
  4. Hepatic venous pressure drainage measurement - Gold standard for measuring portal hypertension.If ore than 5 mmHg it is considered as significant
  5. Portal venography - patency and the calibre of portal vein and splenic vein , presence of collaterals
  6. Liver function tests for liver diseases
  7. Proctoscopy - rectal varices
  8. Barium enema - colonic varices

Patient #1

Patient #2: Recanalized umbilican vein

Treatment

Medical management

Treatment with a non-selective beta blocker is often commenced once portal hypertension has been diagnosed, and almost always if there has already been bleeding from esophageal varices. Typically, this is done with either propranolol or nadolol. The addition of a nitrate, such as isosorbide mononitrate, to the beta blocker is more effective than using beta blockers alone and may be the preferred regimen in those people with portal hypertension who have already experienced variceal bleeding. In acute or severe complications of the hypertension, such as bleeding varices, intravenous octreotide (a somatostatin analogue) or intravenous terlipressin (an antidiuretic hormone analogue) is commenced to decrease the portal pressure.

Percutaneous interventions

Transjugular intrahepatic portosystemic shunting is the creation of a connection between the portal and the venous system. As the pressure over the venous system is lower than over a hypertensive portal system, this would decrease the pressure over the portal system and a decreased risk of complications.

Surgical interventions

The most definitive treatment of portal hypertension is a liver transplant.

References

  1. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:291

External links

Template:Gastroenterology de:Portale Hypertension sv:Portahypertension


Template:WikiDoc Sources